The spine industry has experienced a Renaissance period for the past few decades where innovation truly disrupted the old open spine surgeries of the past, making procedures less risky and painful. Advancement in fusion technology, motion preservation and less invasive procedures dominated recent advancements and additional biologic and regenerative solutions could be on the horizon. But the healthcare environment is changing. Hospitals and insurance companies no longer give a blank check to purchase the latest technology at any price. The Food and Drug Administration updated the device approval process to make it more difficult and expensive to achieve clearance. Additional scrutiny and transparency into the relationships between physicians and device companies make collaboration more difficult. Consolidation in the medical device industry discourages truly disruptive technology development from the inside.
Hey, check out all the engineering jobs. Post your resume today!
